Greater Glasgow and Clyde Medicines

Latest Medicines Updates & News

Formulary Update (April 2017)

Posted: Tuesday, May 2, 2017

Category - Formulary Update

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.

Read More...

Dabigatran: colour change

Posted: Tuesday, April 25, 2017

Category - Medicines Update

The manufacturer of dabigatran (Pradaxa®) has written to healthcare professionals to advise that the colour of the capsule is being changed in a move that is likely to improve patient safety.   Dabig...
Read More...

Sacubitril / valsartan

Posted: Tuesday, April 25, 2017

Category - Medicines Update

Heart MCN Key Message   All new initiations of sacubitril/valsartan must be discussed on an individual patient basis with a consultant with special interest in heart failure. For safety reasons, every patient commenced on...
Read More...

C diff infections and PPIs

Posted: Tuesday, April 25, 2017

Category - Medicines Update

There was an increase in Clostridium difficile infection (CDI) rates within NHSGGC in quarter 3 last year. A review of cases highlighted that almost half of the patients with CDI were prescribed a proton pump inhibitor ...

Read More...

Nystatin Dose Clarification

Posted: Wednesday, April 19, 2017

Category - Medicines Update

In 2016, the dose of nystatin oral suspension was increased in the print issue of BNF 72 (Sept 16 – March 17) and in the BNF for Children (BNFC) 2016-2017. The dose change was in line with the Nystan...

Read More...